18 F-DOPA

DRUG2 trials

Conditions

Congenital HyperinsulinismCongenital Hyperinsulinism (CHI)Hyperinsulinemic Hypoglycemia, PersistentPersistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)

Phase 2

Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia

CompletedNCT01468454

Children's Hospital of PhiladelphiaCongenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)

Start: 2009-01-31End: 2018-02-28Updated: 2022-10-13

Unknown Phase

Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

NCT02533219

Baylor College of MedicineCongenital Hyperinsulinism, Hyperinsulinemic Hypoglycemia, Persistent, Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)

Updated: 2020-09-07

18 F-DOPA

Sponsors

Conditions

Phase 2

Unknown Phase